CVS Health: Q4 EPS down 44%
(CercleFinance.com) - CVS Health has reported Q4 2024 adjusted EPS that is down 44% to $1.
19, with adjusted operating profit down over 35% to $2.73bn, despite revenue rising 4.2% to $97.7bn. NB: pmt +11.4%.
The group explains that its drop in profits was mainly due to declining operating results in the healthcare benefits segment, reflecting continued utilization pressure and an unfavorable impact related to Medicare Advantage star ratings.
Posting FY 2024 adjusted EPS of $5.42 and cash flow from operations of $9.1bn, for 2025 CVS Health target $5.75 to $6, and around $6.5bn respectively.
Copyright (c) 2025 CercleFinance.com. All rights reserved.
19, with adjusted operating profit down over 35% to $2.73bn, despite revenue rising 4.2% to $97.7bn. NB: pmt +11.4%.
The group explains that its drop in profits was mainly due to declining operating results in the healthcare benefits segment, reflecting continued utilization pressure and an unfavorable impact related to Medicare Advantage star ratings.
Posting FY 2024 adjusted EPS of $5.42 and cash flow from operations of $9.1bn, for 2025 CVS Health target $5.75 to $6, and around $6.5bn respectively.
Copyright (c) 2025 CercleFinance.com. All rights reserved.